Subscribe to Newsletter

Akm Khairuzzaman

Akm Khairuzzaman is a Branch Chief at FDA’s Office of Office of Pharmaceutical Quality, CDER, where he leads a group of review scientist responsible for assessment of chemistry, manufacturing, controls (CMC) for investigational new drug applications (IND), new drug application (NDA), and abbreviated new drug application (ANDA) seeking approval in US market.

Content by Akm Khairuzzaman:

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine